NCT06117748

Brief Summary

The aim of this study is to compare the efficacy of the pressure controlled ventilation volume-guaranteed (PCV-VG) versus volume-controlled ventilation (VCV) modes as regards lung compliance and oxygenation index in obese patients undergoing laparoscopic assisted surgery especially in Trendelenburg position.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

November 5, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 7, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

November 7, 2023

Status Verified

November 1, 2023

Enrollment Period

8 months

First QC Date

October 31, 2023

Last Update Submit

November 5, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Oxygenation index

    Oxygenation index =mean airway pressure × fraction of inspired oxygen (FiO2) × 100÷ Partial pressure of oxygen (PaO2)

    Till the end of surgery

Secondary Outcomes (5)

  • Mean arterial blood pressure

    Till the end of surgery

  • Heart rate

    Till the end of surgery

  • Oxygen saturation SpO2

    Till the end of surgery

  • Arterial PCo2

    Till the end of surgery

  • Lung compliance

    Till the end of surgery

Study Arms (2)

Group (PCV-VG): Pressure controlled ventilation-volume guaranteed

EXPERIMENTAL

Patients will receive pressure controlled ventilation-volume guaranteed

Other: Pressure controlled ventilation-volume guaranteed

Group (VCV): Volume controlled ventilation

OTHER

Patients will receive Volume controlled ventilation

Other: Volume controlled ventilation

Interventions

Respiratory parameters will be set as: actual tidal volume 8 mL/kg actual body weight, respiratory rate 12 breaths/min, PEEP of five mmHg, oxygen flow 1 L/min, fraction inspired oxygen (FiO2) 0.6, and I:E ratio of 1:2. Respiratory parameters will be kept constant if ETCO2 is \<45 mmHg. When ETCO2 exceed 45 mmHg, respiratory rate or tidal volume will be adjusted to maintain ETCO2 below 45 mmHg.

Group (PCV-VG): Pressure controlled ventilation-volume guaranteed

Respiratory parameters will be set as: actual tidal volume 8 mL/kg actual body weight, respiratory rate 12 breaths/min, PEEP of five mmHg, oxygen flow 1 L/min, fraction inspired oxygen (FiO2) 0.6, and I:E ratio of 1:2. Respiratory parameters will be kept constant if ETCO2 is \<45 mmHg. When ETCO2 exceed 45 mmHg, respiratory rate or tidal volume will be adjusted to maintain ETCO2 below 45 mmHg.

Group (VCV): Volume controlled ventilation

Eligibility Criteria

Age16 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age: 16 - 60 years old.
  • Sex: both males and females.
  • Undergoing elective Laparoscopic Surgery.
  • Obese patient with Body Mass Index between ≥30 Kg/m2.
  • American society of Anesthesiologist (ASA) class I/ II.

You may not qualify if:

  • Patient refusal.
  • American society of Anesthesiology (ASA) III or IV.
  • Intraoperative hemodynamic instability.
  • Patients with pulmonary hypertension.
  • Obese patients on home O2 therapy
  • Pneumoperitoneum with CO2 with intra-abdominal pressure exceeding 15mmHg.
  • Anti-Trendelenburg position.
  • Asthmatic Patients.
  • Patients with advanced liver disease.
  • Patients with advanced renal disease.
  • Patients with advanced malignancy.
  • Pregnant females.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University

Cairo, 11591, Egypt

RECRUITING

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine

Study Record Dates

First Submitted

October 31, 2023

First Posted

November 7, 2023

Study Start

November 5, 2023

Primary Completion

July 1, 2024

Study Completion

July 1, 2024

Last Updated

November 7, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author.

Locations